PRICE T ROWE ASSOCIATES INC /MD/ - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 63 filers reported holding VIRACTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$296,000
-96.5%
81,136
-92.4%
0.00%
-100.0%
Q3 2021$8,572,000
+81.7%
1,068,812
+109.6%
0.00%
Q1 2021$4,718,000510,0000.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 288,571$406,8850.20%
Samsara BioCapital, LLC 689,709$972,4900.17%
BVF INC/IL 3,614,662$5,096,6730.14%
TRUST CO OF TOLEDO NA /OH/ 35,006$49,3580.01%
Laurion Capital Management LP 698,000$984,1800.01%
MAI Capital Management 307,570$433,6740.01%
RP Management, LLC 3,700$5,2170.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 125,000$176,2500.00%
UNITED BANK 10,205$14,3890.00%
BOURGEON CAPITAL MANAGEMENT LLC 7,500$10,5750.00%
View complete list of VIRACTA THERAPEUTICS INC shareholders